Diabetic Peripheral Neuropathy Treatment Market Report

Global and Region Diabetic Peripheral Neuropathy Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：141
  • REPORT CODE：GMM920397
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Diabetic Peripheral Neuropathy Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Diabetic Peripheral Neuropathy Treatmentmarket, defines the market attractiveness level of Diabetic Peripheral Neuropathy Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Diabetic Peripheral Neuropathy Treatment industry, describes the types of Diabetic Peripheral Neuropathy Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Diabetic Peripheral Neuropathy Treatment market and the development prospects and opportunities of Diabetic Peripheral Neuropathy Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Diabetic Peripheral Neuropathy Treatment market in Chapter 13.

    By Player:

    • Achelios Therapeutics Inc

    • Medifron DBT Co Ltd

    • Relief Therapeutics Holding AG

    • Mitsubishi Tanabe Pharma Corp

    • Immune Pharmaceuticals Inc

    • Commence Bio Inc

    • Novaremed Ltd

    • Grunenthal GmbH

    • KPI Therapeutics Inc

    • ViroMed Co Ltd

    • Celgene Corp

    • Reata Pharmaceuticals Inc

    By Type:

    • Antimunocel

    • ASP-8477

    • BNV-222

    • Capsaicin

    • CBX-129801

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Diabetic Peripheral Neuropathy Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Diabetic Peripheral Neuropathy Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Diabetic Peripheral Neuropathy Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Diabetic Peripheral Neuropathy Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Diabetic Peripheral Neuropathy Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Diabetic Peripheral Neuropathy Treatment Consumption (2017-2022)

    • 7.2 United States Diabetic Peripheral Neuropathy Treatment Consumption (2017-2022)

    • 7.3 Europe Diabetic Peripheral Neuropathy Treatment Consumption (2017-2022)

    • 7.4 China Diabetic Peripheral Neuropathy Treatment Consumption (2017-2022)

    • 7.5 Japan Diabetic Peripheral Neuropathy Treatment Consumption (2017-2022)

    • 7.6 India Diabetic Peripheral Neuropathy Treatment Consumption (2017-2022)

    • 7.7 South Korea Diabetic Peripheral Neuropathy Treatment Consumption (2017-2022)

    8 Region and Country-wise Diabetic Peripheral Neuropathy Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2022-2028)

    • 8.4 China Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2022-2028)

    • 8.6 India Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2022-2028)

    9 Global Diabetic Peripheral Neuropathy Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Diabetic Peripheral Neuropathy Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Antimunocel Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global ASP-8477 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global BNV-222 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Capsaicin Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global CBX-129801 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Diabetic Peripheral Neuropathy Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Diabetic Peripheral Neuropathy Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Diabetic Peripheral Neuropathy Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Antimunocel Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global ASP-8477 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global BNV-222 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Capsaicin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global CBX-129801 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Diabetic Peripheral Neuropathy Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Diabetic Peripheral Neuropathy Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Diabetic Peripheral Neuropathy Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Diabetic Peripheral Neuropathy Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Diabetic Peripheral Neuropathy Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Diabetic Peripheral Neuropathy Treatment Market Competitive Analysis

    • 14.1 Achelios Therapeutics Inc

      • 14.1.1 Achelios Therapeutics Inc Company Details

      • 14.1.2 Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.2 Medifron DBT Co Ltd

      • 14.2.1 Medifron DBT Co Ltd Company Details

      • 14.2.2 Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.3 Relief Therapeutics Holding AG

      • 14.3.1 Relief Therapeutics Holding AG Company Details

      • 14.3.2 Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.4 Mitsubishi Tanabe Pharma Corp

      • 14.4.1 Mitsubishi Tanabe Pharma Corp Company Details

      • 14.4.2 Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.5 Immune Pharmaceuticals Inc

      • 14.5.1 Immune Pharmaceuticals Inc Company Details

      • 14.5.2 Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.6 Commence Bio Inc

      • 14.6.1 Commence Bio Inc Company Details

      • 14.6.2 Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.7 Novaremed Ltd

      • 14.7.1 Novaremed Ltd Company Details

      • 14.7.2 Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.8 Grunenthal GmbH

      • 14.8.1 Grunenthal GmbH Company Details

      • 14.8.2 Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.9 KPI Therapeutics Inc

      • 14.9.1 KPI Therapeutics Inc Company Details

      • 14.9.2 KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.10 ViroMed Co Ltd

      • 14.10.1 ViroMed Co Ltd Company Details

      • 14.10.2 ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.11 Celgene Corp

      • 14.11.1 Celgene Corp Company Details

      • 14.11.2 Celgene Corp Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Celgene Corp Diabetic Peripheral Neuropathy Treatment Product and Service

    • 14.12 Reata Pharmaceuticals Inc

      • 14.12.1 Reata Pharmaceuticals Inc Company Details

      • 14.12.2 Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Diabetic Peripheral Neuropathy Treatment

    • Figure Diabetic Peripheral Neuropathy Treatment Picture

    • Table Global Diabetic Peripheral Neuropathy Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diabetic Peripheral Neuropathy Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diabetic Peripheral Neuropathy Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Diabetic Peripheral Neuropathy Treatment Consumption by Country (2017-2022)

    • Figure United States Diabetic Peripheral Neuropathy Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Diabetic Peripheral Neuropathy Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Diabetic Peripheral Neuropathy Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Diabetic Peripheral Neuropathy Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Diabetic Peripheral Neuropathy Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Diabetic Peripheral Neuropathy Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetic Peripheral Neuropathy Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Diabetic Peripheral Neuropathy Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Diabetic Peripheral Neuropathy Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Diabetic Peripheral Neuropathy Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Diabetic Peripheral Neuropathy Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Diabetic Peripheral Neuropathy Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Diabetic Peripheral Neuropathy Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antimunocel Consumption and Growth Rate (2017-2022)

    • Figure Global ASP-8477 Consumption and Growth Rate (2017-2022)

    • Figure Global BNV-222 Consumption and Growth Rate (2017-2022)

    • Figure Global Capsaicin Consumption and Growth Rate (2017-2022)

    • Figure Global CBX-129801 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Antimunocel Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ASP-8477 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BNV-222 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Capsaicin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CBX-129801 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Diabetic Peripheral Neuropathy Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Diabetic Peripheral Neuropathy Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Achelios Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table Medifron DBT Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table Relief Therapeutics Holding AG (Foundation Year, Company Profile and etc.)

    • Table Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table Mitsubishi Tanabe Pharma Corp (Foundation Year, Company Profile and etc.)

    • Table Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table Immune Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table Commence Bio Inc (Foundation Year, Company Profile and etc.)

    • Table Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table Novaremed Ltd (Foundation Year, Company Profile and etc.)

    • Table Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table Grunenthal GmbH (Foundation Year, Company Profile and etc.)

    • Table Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table KPI Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table ViroMed Co Ltd (Foundation Year, Company Profile and etc.)

    • Table ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table Celgene Corp (Foundation Year, Company Profile and etc.)

    • Table Celgene Corp Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corp Diabetic Peripheral Neuropathy Treatment Product and Service

    • Table Reata Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US